Skip to content
Screener

Celldex Therapeutics CLDX Other Research And Development Expense

Other Research And Development Expense at other companies

Solid Biosciences Inc. logo
Solid Biosciences Inc.SLDB
$1.98M-36.4%
OS Therapies logo
OS TherapiesOSTX
$0—
RFL
Rafael Holdings, Inc.RFL
$22K-51.1%
CTO
Citius Oncology, Inc.CTOR
$469K-2.3%
TG Therapeutics logo
TG TherapeuticsTGTX
$87.27M+218%
TG Therapeutics logo
TG TherapeuticsTGTX
$87.27M+218%

Segments

By segment

See full
Single Reportable$6.14M+71.1%

Other financials

Income statement

See full
Revenue$22.0K-97.0%
Operating income-$80.6M-26.3%
Net income-$73.5M-29.9%
EPS (diluted)-$0.94-10.6%

Balance sheet

See full
Cash & equivalents$47.5M+106%
Total debt$4.9M+61.8%
Total equity$714.6M+9.0%
Total assets$782.3M+13.0%

Cash flow

See full
Operating cash flow-$57.4M-30.5%
CapEx$3.2M+337%
Free cash flow-$60.6M-35.4%

Valuation

See full
Market cap$3.26B+129%
Enterprise value$3.22B+129%
P/S20,646.4×+20,401×

Profitability

See full
Operating margin-206,220.3%-210,440pp
Net margin-190,220.9%-193,797pp
FCF margin-153,231%-156,630pp

Returns & leverage

See full
Return on equity-43.9%+70.0pp
Debt / equity0×0.0×
Current ratio11.8×-7.8×